Participants
| Role | Name | HCID | Charge |
|---|
| Reactant | Methanol | HCID 887 | — |
| Reactant | 1,4-Dioxane | HCID 31275 | — |
| Reactant | Quinazoline, 2,4-bis[(trimethylsilyl)oxy]- | HCID 11088105 | — |
| Reactant | Methyl 5-(bromomethyl)-2-fluorobenzoate | HCID 22645461 | — |
| Solvent | Dimethylformamide | HCID 6228 | — |
| Product | HCID 68388650 | HCID 68388650 | — |
Reaction Steps
Compounds of this invention can be prepared as illustrated by the exemplary reaction in Scheme 2. Reaction of the intermediate 2,4-di(trimethylsiloxy)quinazoline with a substituted alkyl 3-(halomethyl)benzoate, such as methyl 5-(bromomethyl)-2-fluorobenzoate in DMF, followed by treatment with 1,4-dioxane and methanol, produced 1-(4-fluoro-3-methoxycarbonylbenzyl)quinazoline-2,4(1H,3H)-dione. Treatment of the ester with NaOH in water-methanol produced 1-(3-carboxy-4-fluorobenzyl)quinazoline-2,4(1H,3H)-dione. Coupling of the acid with a substituted amine, such as 1-cyclopentylcarbonylpiperazine, in the presence of coupling agents, such as HATU and DIPEA in DMF, produced the targeted compound 1-(3-(4-cyclopentylcarbonylpiperazine-1-carbonyl)-4-fluorobenzyl)quinazoline-2,4(1H,3H)-dione.
Provenance & Evidence
| DOI | 10.6084/m9.figshare.5104873.v1 |
|---|
| Patent number | US09290460B2 |
|---|
| Source dataset | uspto-grants-2016_03 |
|---|
| ORD ID | ord-25a18ebc5a6841b2b737df13f3ef799c |
|---|
| Source note | uspto-grants-2016_03 |
|---|